We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LABP market cap is 69.5M. The company's latest EPS is USD -7.0378 and P/E is -3.17.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.51M | -6.48M | -4.44M | -5.2M | -6.61M |
| Net Income | -5.23M | -6.03M | -3.92M | -5.86M | -6.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 18M | 0 | 0 |
| Operating Income | -13.29M | -30.68M | -38.82M | -40.56M | -22.73M |
| Net Income | -13.47M | -30.14M | -38.42M | -39.28M | -21.94M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 45.25M | 51.18M | 46.29M | 43.23M | 38.04M |
| Total Liabilities | 6.12M | 4.16M | 3.02M | 5.57M | 6.25M |
| Total Equity | 39.13M | 47.02M | 43.27M | 37.66M | 31.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 50.48M | 30.33M | 92.88M | 45.25M | 38.04M |
| Total Liabilities | 3.03M | 11.31M | 16.61M | 6.12M | 6.25M |
| Total Equity | -25.58M | -54.02M | 76.27M | 39.13M | 31.79M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -45.77M | -8.17M | -13.28M | -15.51M | -20.48M |
| Investing | 74.06M | 3.1M | 7.08M | 7.71M | 7.78M |
| Financing | N/A | 13.67M | 13.57M | 13.57M | 13.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.87M | -22.96M | -27.06M | -45.77M | -20.48M |
| Investing | -40.33M | 14.13M | -58.71M | 74.06M | 7.78M |
| Financing | 59.65M | 1.52M | 91.61M | N/A | 13.57M |
| Market Cap | 69.5M |
| Price to Earnings Ratio | -3.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.85 |
| Price to Book Ratio | 2.19 |
| Dividend Yield | - |
| Shares Outstanding | 3.12M |
| Average Volume (1 week) | 7.02k |
| Average Volume (1 Month) | 7.39k |
| 52 Week Change | 668.97% |
| 52 Week High | 22.6747 |
| 52 Week Low | 2.50 |
| Spread (Intraday) | 0.25 (1.11%) |
| Company Name | Landos Biopharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.landosbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
